Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2

In conclusion, our findings do not support a pathogenic role of the Leu56Met variant in MEN 2.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research